.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents and 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Federal Trade Commission
Colorcon
Teva
Accenture
Julphar
Dow
Cantor Fitzgerald
Chinese Patent Office
Mallinckrodt

Generated: June 24, 2017

DrugPatentWatch Database Preview

DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Drospirenone, Ethinyl Estradiol And Levomefolate Calcium, and when can generic versions of Drospirenone, Ethinyl Estradiol And Levomefolate Calcium launch?

Drospirenone, Ethinyl Estradiol And Levomefolate Calcium is a drug marketed by Watson Labs Inc and is included in two NDAs.

The generic ingredient in DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM is drospirenone; ethinyl estradiol; levomefolate calcium. There are ten drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol; levomefolate calcium profile page.

Summary for Tradename: DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Clinical Trials: see list104,440
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Inc
DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM
drospirenone; ethinyl estradiol; levomefolate calcium
TABLET;ORAL203593-001Oct 11, 2016ABRXNoNo► Subscribe► Subscribe
Watson Labs Inc
DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM
drospirenone; ethinyl estradiol; levomefolate calcium
TABLET;ORAL203594-001Oct 11, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Chubb
Boehringer Ingelheim
Fish and Richardson
US Department of Justice
Cantor Fitzgerald
Dow
Novartis
Daiichi Sankyo
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot